Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,236 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Rationale and design of a randomized pragmatic trial of patient-centered models of hepatitis C treatment for people who inject drugs: The HERO study.
Litwin AH, Jost J, Wagner K, Heo M, Karasz A, Feinberg J, Kim AY, Lum PJ, Mehta SH, Taylor LE, Tsui JI, Pericot-Valverde I, Page K; HERO Study Group. Litwin AH, et al. Among authors: page k. Contemp Clin Trials. 2019 Dec;87:105859. doi: 10.1016/j.cct.2019.105859. Epub 2019 Oct 24. Contemp Clin Trials. 2019. PMID: 31669450 Free PMC article.
Cohort profile: the international collaboration of incident HIV and hepatitis C in injecting cohorts (InC3) study.
Grebely J, Morris MD, Rice TM, Bruneau J, Cox AL, Kim AY, McGovern BH, Shoukry NH, Lauer G, Maher L, Lloyd AR, Hellard M, Prins M, Dore GJ, Page K; InC Study Group. Grebely J, et al. Among authors: page k. Int J Epidemiol. 2013 Dec;42(6):1649-59. doi: 10.1093/ije/dys167. Epub 2012 Nov 30. Int J Epidemiol. 2013. PMID: 23203695 Free PMC article.
Interferon lambda 3 genotype predicts hepatitis C virus RNA levels in early acute infection among people who inject drugs: the InC(3) study.
Hajarizadeh B, Grady B, Page K, Kim AY, McGovern BH, Cox AL, Rice TM, Sacks-Davis R, Bruneau J, Morris M, Amin J, Schinkel J, Applegate T, Maher L, Hellard M, Lloyd AR, Prins M, Geskus RB, Dore GJ, Grebely J; InC(3)Study Group. Hajarizadeh B, et al. Among authors: page k. J Clin Virol. 2014 Nov;61(3):430-4. doi: 10.1016/j.jcv.2014.08.027. Epub 2014 Sep 8. J Clin Virol. 2014. PMID: 25256151 Free PMC article.
Patterns of hepatitis C virus RNA levels during acute infection: the InC3 study.
Hajarizadeh B, Grady B, Page K, Kim AY, McGovern BH, Cox AL, Rice TM, Sacks-Davis R, Bruneau J, Morris M, Amin J, Schinkel J, Applegate T, Maher L, Hellard M, Lloyd AR, Prins M, Dore GJ, Grebely J; InC3 Study Group. Hajarizadeh B, et al. Among authors: page k. PLoS One. 2015 Apr 2;10(4):e0122232. doi: 10.1371/journal.pone.0122232. eCollection 2015. PLoS One. 2015. PMID: 25837807 Free PMC article.
Hepatitis C Virus Reinfection and Spontaneous Clearance of Reinfection--the InC3 Study.
Sacks-Davis R, Grebely J, Dore GJ, Osburn W, Cox AL, Rice TM, Spelman T, Bruneau J, Prins M, Kim AY, McGovern BH, Shoukry NH, Schinkel J, Allen TM, Morris M, Hajarizadeh B, Maher L, Lloyd AR, Page K, Hellard M; InC3 study group. Sacks-Davis R, et al. Among authors: page k. J Infect Dis. 2015 Nov 1;212(9):1407-19. doi: 10.1093/infdis/jiv220. Epub 2015 Apr 15. J Infect Dis. 2015. PMID: 25883387 Free PMC article.
1,236 results